KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Diluted Average) (2016 - 2026)

Neogenomics filings provide 15 years of Shares Outstanding (Diluted Average) readings, the most recent being $129.2 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.41% to $129.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $129.2 million, a 1.41% increase, with the full-year FY2025 number at $128.1 million, up 1.14% from a year prior.
  • Shares Outstanding (Diluted Average) hit $129.2 million in Q1 2026 for Neogenomics, up from $128.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $129.2 million in Q1 2026 to a low of $123.6 million in Q1 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $126.1 million (2024), compared with a mean of $126.1 million.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 6.4% in 2022, down 5.46% in 2022.
  • Neogenomics' Shares Outstanding (Diluted Average) stood at $124.2 million in 2022, then grew by 1.03% to $125.5 million in 2023, then grew by 0.92% to $126.7 million in 2024, then rose by 1.14% to $128.1 million in 2025, then increased by 0.83% to $129.2 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $129.2 million (Q1 2026), $128.1 million (Q4 2025), and $127.9 million (Q3 2025) per Business Quant data.